Tirzepatide in type 1 diabetes: beyond mere weight loss
Expert Review of Clinical Pharmacology · 03.07.2026 · 19 (7) · 687-696
DOI: 10.1080/17512433.2026.2685653 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Expert Review of Clinical Pharmacology, online erschienen am 11.06.2026. Verfasst von Theodoros Panou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Diabetes Centre-Diabetic Foot Clinic, Second Department of Internal Medicine, Democritus University of Thrace, Alexandroupolis, Greece. Hauptthemen laut MEDLINE: Tirzepatide, Diabetes Mellitus, Type 1, Hypoglycemic Agents, Glucagon-Like Peptide-1 Receptor Agonists. Die Arbeit nennt 85 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Diabetes Centre-Diabetic Foot Clinic, Second Department of Internal Medicine, Democritus University of Thrace, Alexandroupolis, Greece.
- Clinic for Endocrinology, Diabetes and Metabolic Disorders, Clinical Center of Vojvodina, Novi Sad, Serbia.
- Medical Faculty, University of Novi Sad, Novi Sad, Serbia.
Zitieren
APA
Panou, T., Gouveri, E., Popovic, D. S., & Papanas, N. (2026). Tirzepatide in type 1 diabetes: beyond mere weight loss. Expert Review of Clinical Pharmacology, 19(7), 687-696. https://doi.org/10.1080/17512433.2026.2685653
Vancouver
Panou T, Gouveri E, Popovic DS, Papanas N. Tirzepatide in type 1 diabetes: beyond mere weight loss. Expert Review of Clinical Pharmacology. 2026;19(7):687-696. doi:10.1080/17512433.2026.2685653
BibTeX
@article{Panou2026,
author = {Panou, Theodoros and Gouveri, Evanthia and Popovic, Djordje S and Papanas, Nikolaos},
title = {Tirzepatide in type 1 diabetes: beyond mere weight loss},
journal = {Expert Review of Clinical Pharmacology},
year = {2026},
volume = {19},
number = {7},
pages = {687--696},
doi = {10.1080/17512433.2026.2685653}
}
EUVIMED